Inscription Capital’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
4,057
+2,033
+100% +$191K 0.03% 554
2026
Q1
$239K Buy
+2,024
New +$250K 0.03% 555
2025
Q4
– Sell
-3,443
Closed -$504K – 757
2025
Q3
$504K Buy
3,443
+1,175
+52% +$178K 0.05% 354
2025
Q2
$354K Buy
+2,268
New +$360K 0.05% 309
2021
Q3
– Sell
-6,030
Closed -$1.12M – 408
2021
Q2
$1.12M Buy
+6,030
New +$1.05M 0.13% 122

Other funds holding ZTS

Inscription Capital's ZTS Position: Q2 2026 in Review

Inscription Capital increased its Zoetis (ZTS) stake by 100% in Q2 2026, buying an estimated $191K and bringing the position to 4,057 shares worth $292K. The position accounts for 0.03% of the portfolio, ranked #554.

Inscription Capital first reported a position in ZTS in Q2 2021 and has held it in 5 quarters since. The position peaked at $1.12M in Q2 2021. 1,435 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Inscription Capital held 4,057 shares of Zoetis worth $292K as of Q2 2026.
  • Inscription Capital bought 2,033 Zoetis shares in Q2 2026, an estimated $191K.
  • Zoetis made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #554 holding.
  • Inscription Capital first reported a position in Zoetis in Q2 2021 and has held it in 5 quarters since.
  • Inscription Capital's Zoetis position peaked at $1.12M in Q2 2021.
  • 1,435 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.